Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Tonix Pharmaceuticals Q1 2024 GAAP EPS $(0.18) Beats $(0.39) Estimate, Sales $2.482M Miss $3.800M Estimate

Author: Benzinga Newsdesk | May 13, 2024 04:42pm
Tonix Pharmaceuticals (NASDAQ:TNXP) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(0.39) by 53.85 percent. The company reported quarterly sales of $2.482 million which missed the analyst consensus estimate of $3.800 million by 34.68 percent.

Posted In: TNXP


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist